Related Experiment Video
Updated: Jul 9, 2026

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C
Published on: March 25, 2016
Maternal autoimmune systemic connective tissue disease and vasculitis and electrocardiographic findings in the
Sarah Sofie Andersen1, Terese Frellesen Neumann1, Sofie Dannesbo1
1Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Insights
Neonates exposed to maternal autoimmune diseases generally showed normal ECGs. However, those exposed to antiphospholipid syndrome had longer QRS and QTc intervals, warranting further study.
Area of Science:
- Cardiology
- Neonatology
- Rheumatology
Background:
- Maternal autoimmune systemic connective tissue diseases (CTDs) and associated antibodies are linked to adverse fetal outcomes.
- Previous research suggests a connection between maternal CTDs and neonatal heart conditions like complete heart block.
Purpose of the Study:
- To investigate the association between maternal CTD or vasculitis and neonatal electrocardiographic (ECG) parameters.
- To compare ECG parameters in neonates exposed to maternal CTDs/vasculitis versus unexposed controls.
Main Methods:
- Prospective, population-based cohort study (Copenhagen Baby Heart Study) of neonates.
- Matching exposed neonates (mothers with CTD/vasculitis) 1:3 to unexposed controls based on demographic and clinical factors.
- Validation of maternal diagnoses via medical record review and comparison of ECG parameters.
Main Results:
- No significant overall differences in ECG parameters (heart rate, PR interval, QRS axis, QRS duration, QT/QTc interval, wave amplitudes) between exposed and unexposed neonates.
- Neonates born to mothers with antiphospholipid syndrome showed significantly longer QRS duration and corrected QT (QTc) intervals compared to controls.
- Subanalyses for anti-Ro/SSA antibodies did not reveal significant between-group differences.
Conclusions:
- Overall, maternal CTD or vasculitis did not significantly alter neonatal ECG parameters in this cohort.
- Neonates exposed to maternal antiphospholipid syndrome exhibited prolonged QRS and QTc intervals, suggesting a potential specific impact.
- Further research in larger cohorts is needed to understand the clinical implications of these findings.
Introduction:
Maternal autoimmune systemic connective tissue diseases (CTDs) and their related antibodies have been associated with adverse fetal outcomes, including complete heart block. In this study, we assessed the association between maternal CTD or vasculitis and neonatal electrocardiographic (ECG) parameters.
Methods:
Our study population was drawn from the Copenhagen Baby Heart Study (CBHS), a prospective, population-based cohort study open to all neonates born in the Copenhagen area. All CBHS neonates born to mothers with CTD or vasculitis were matched 1:3 to neonates born to mothers without these diseases on sex, gestational age, age and weight at time of examination, and maternal age at delivery. Maternal CTD and vasculitis diagnoses were validated through medical record review. Our primary analyses compared ECG parameters for exposed and unexposed neonates overall. Where numbers allowed, subanalyses were then conducted by specific CTD diagnoses and autoantibody types.
Results:
Among 17,862 CBHS neonates with an available ECG, 40 neonates of mothers with CTDs or vasculitis (50 % males, median age 12 [interquartile range 8-16] days) were matched to unexposed neonates. Overall, no significant differences in heart rate, PR interval, QRS axis, QRS duration, QT/QTc interval, or R- or S-wave amplitudes were found when comparing exposed and unexposed neonates (all p > 0.05). Similarly, separate analyses of the 10 neonates with anti-Ro/SSA-positive mothers and their matched comparators revealed no significant between-group differences. However, neonates born to mothers with antiphospholipid syndrome (n = 15) had a significantly longer QRS duration (median 56 ms vs. 52 ms, p = 0.02) and corrected QT interval (median QTcBaz 430 ms vs. 414 ms, p = 0.01), compared with matched unexposed neonates.
Conclusion:
In this population-based study, no significant overall differences in ECG parameters were found between neonates exposed to maternal CTD or vasculitis and unexposed neonates. However, neonates exposed to maternal antiphospholipid syndrome had significantly longer QRS- and QTc intervals than unexposed neonates. The potential clinical implications of these findings are unknown and, combined with the limitations of this study, warrant further investigation in larger cohorts.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

